Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase 3 Trial of Chemotherapy ± Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)
Year: 2011
Type: article
Source: European Journal of Cancer
Authors: C. Aghajanian, S.V. Blank, B. Goff, P.L. Judson, S. Makhija, S.K. Sharma, L.R. Nycum, J. Yi, A. Husain
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2077428792